# X4 Pharmaceuticals, Inc — Form D

X4 Pharmaceuticals, Inc of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-27. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-04-27
- Form: D
- Accession: 0001501697-16-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $15.0M
- Investors: 10
- Date of first sale: 2016-04-12
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-262117

## Issuer

- Name: X4 Pharmaceuticals, Inc
- CIK: 0001501697
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 61 NORTH BEACON STREET, BOSTON, MA, 02134
- Phone: 857-529-8300

## Officers, directors & promoters (72)

_Showing 25 of 72 people._

| Name | Role | Location |
| --- | --- | --- |
| Jan Adams | Director | Waltham, MA |
| Daniel Burgess | Director | NESS ZIONA, L3 |
| Tillman Gerngross | Director | Waltham, MA |
| CARL GORDON | Director | SAN DIEGO, CA |
| Terrance McGuire | Director | Cambridge, MA |
| Eszter Nagy | Director | Waltham, MA |
| Claudio Nessi | Director | Philadelphia, PA |
| Michael Ross | Director | South San Francisco, CA |
| Amy Schulman | Director | Cambridge, MA |
| Tillman Gerngross | Executive Officer | Waltham, MA |
| Eszter Nagy | Executive Officer | Waltham, MA |
| Michael Gray | Executive Officer | Vancouver, A1 |
| Mary DiBiase | Executive Officer | BOSTON, MA |
| Murray W Stewart | Director | BOSTON, MA |
| Christophe Arbet-Engels | Executive Officer | BOSTON, MA |
| David Kirske | Executive Officer | BOSTON, MA |
| Michael S Wyzga | Director | BOSTON, MA |
| John Volpone | Executive Officer | BOSTON, MA |
| Mark Baldry | Executive Officer | BOSTON, MA |
| Francoise J De Craecker | Director | BOSTON, MA |
| Gary J Bridger | Director | BOSTON, MA |
| Adam Craig | Director | BOSTON, MA |
| Adam Craig | Executive Officer | BOSTON, MA |
| Adam Mostafa | Executive Officer | Toronto, A6 |
| David McGirr | Director | Boston, MA |

## Other filings by this issuer (11)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-08-25](https://search.stillhousedata.com/formd/0001470831-25-000145) | D | $85.0M | $85.0M |
| [2023-06-01](https://search.stillhousedata.com/formd/0001231919-23-000037) | D | $65.0M | $65.0M |
| [2022-07-19](https://search.stillhousedata.com/formd/0001231919-22-000047) | D | $111.5M | $55.7M |
| [2017-12-04](https://search.stillhousedata.com/formd/0001501697-17-000004) | D | $20.0M | $20.0M |
| [2017-05-08](https://search.stillhousedata.com/formd/0001501697-17-000002) | D | $50.5M | $45.5M |
| [2015-12-30](https://search.stillhousedata.com/formd/0001501697-15-000004) | D | $4.0M | $4.0M |
| [2015-06-05](https://search.stillhousedata.com/formd/0001501697-15-000003) | D/A | $20.0M | $20.0M |
| [2014-08-11](https://search.stillhousedata.com/formd/0001501697-14-000001) | D/A | $20.0M | $13.0M |
| [2013-08-13](https://search.stillhousedata.com/formd/0001501697-13-000002) | D | $20.0M | $13.0M |
| [2011-02-07](https://search.stillhousedata.com/formd/0001501697-11-000001) | D | $9.6M | $9.6M |
| [2010-09-24](https://search.stillhousedata.com/formd/0001501697-10-000001) | D | $400K | $400K |

## More

- [CIK 1501697 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1501697&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001501697-16-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.